검색
Exact Sciences Corp
EXAS관심 목록에 추가
104.910USD
0.0000.00%
시장 운영 시간 （ET）시세는 15분 지연됩니다
20.03B시가총액
손실P/E TTM
자세한 내용은 Exact Sciences Corp 회사
Exact Sciences Corporation is a provider of cancer screening and diagnostic tests. The Company provides a portfolio of products for earlier cancer detection and treatment guidance. Its products and services focus on screening and precision oncology tests. It is focusing its research and development efforts on three main areas: Colorectal Cancer Screening Test Development, MCED Test Development and MRD Test Development. Its products and services include Cologuard test, Oncotype DX Breast Recurrence Score Test, Oncotype DX Breast DCIS Score Test, Oncotype DX Colon Recurrence Score Test, OncoExTra Test, and Riskguard Test. Its flagship screening product, the Cologuard test, is a non-invasive, stool-based deoxyribonucleic acid (sDNA) screening test that utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The Oncotype DX Breast Recurrence Score test examines the activity of 21 genes in a patient’s breast tumor tissue.
Exact Sciences Corp 정보
종목 코드 EXAS
회사 이름Exact Sciences Corp
상장일Jan 30, 2001
CEOConroy (Kevin T)
직원 수6900
유형Ordinary Share
회계 연도 종료Jan 30
주소5505 Endeavor Lane
도시MADISON
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호53719
전화16082845700
웹사이트https://www.exactsciences.com/
종목 코드 EXAS
상장일Jan 30, 2001
CEOConroy (Kevin T)
Exact Sciences Corp의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Kevin T. Conroy
Mr. Kevin T. Conroy
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
279.16K
-457.95%
Mr. Daniel J. (Dan) Levangie
Mr. Daniel J. (Dan) Levangie
Independent Director
Independent Director
34.31K
+15.73%
Ms. Shacey Petrovic
Ms. Shacey Petrovic
Independent Director
Independent Director
7.09K
-307.32%
Mr. Brian Baranick
Mr. Brian Baranick
Executive Vice President, General Manager - Precision Oncology
Executive Vice President, General Manager - Precision Oncology
670.00
-15503.58%
Mr. Aaron Bloomer
Mr. Aaron Bloomer
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
212.00
-23003.77%
Ms. Katherine S. (Kay) Zanotti
Ms. Katherine S. (Kay) Zanotti
Independent Director
Independent Director
--
-100.00%
Mr. James E. Doyle
Mr. James E. Doyle
Lead Independent Director
Lead Independent Director
--
--
Mr. D. Scott Coward
Mr. D. Scott Coward
Director
Director
--
--
Mr. Jacob (Jake) Orville
Mr. Jacob (Jake) Orville
Executive Vice President, General Manager - Screening
Executive Vice President, General Manager - Screening
--
--
Mr. Paul Clancy
Mr. Paul Clancy
Independent Director
Independent Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Kevin T. Conroy
Mr. Kevin T. Conroy
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
279.16K
-457.95%
Mr. Daniel J. (Dan) Levangie
Mr. Daniel J. (Dan) Levangie
Independent Director
Independent Director
34.31K
+15.73%
Ms. Shacey Petrovic
Ms. Shacey Petrovic
Independent Director
Independent Director
7.09K
-307.32%
Mr. Brian Baranick
Mr. Brian Baranick
Executive Vice President, General Manager - Precision Oncology
Executive Vice President, General Manager - Precision Oncology
670.00
-15503.58%
Mr. Aaron Bloomer
Mr. Aaron Bloomer
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
212.00
-23003.77%
Ms. Katherine S. (Kay) Zanotti
Ms. Katherine S. (Kay) Zanotti
Independent Director
Independent Director
--
-100.00%
수익 분석
통화: USD마지막 업데이트: Mon, Apr 6
통화: USD마지막 업데이트: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
사업별USD
이름
수익
비율
Commercial
1.52B
46.79%
Medicare Parts B & C
1.15B
35.46%
Other
352.22M
10.85%
International
223.84M
6.89%
지역별USD
이름
수익
비율
United States (Country)
3.02B
93.11%
Outside of united states
223.84M
6.89%
사업별
지역별
사업별USD
이름
수익
비율
Commercial
1.52B
46.79%
Medicare Parts B & C
1.15B
35.46%
Other
352.22M
10.85%
International
223.84M
6.89%
주식 보유 통계
마지막 업데이트: Sun, May 10
마지막 업데이트: Sun, May 10
주주
주주 유형
주주
주주
비율
HBK Investments, L.P.
4.01%
BlackRock Institutional Trust Company, N.A.
3.81%
Pentwater Capital Management LP
3.80%
BlackRock Financial Management, Inc.
2.62%
State Street Investment Management (US)
2.19%
기타
83.58%
주주
주주
비율
HBK Investments, L.P.
4.01%
BlackRock Institutional Trust Company, N.A.
3.81%
Pentwater Capital Management LP
3.80%
BlackRock Financial Management, Inc.
2.62%
State Street Investment Management (US)
2.19%
기타
83.58%
주주 유형
주주
비율
Hedge Fund
25.83%
Investment Advisor/Hedge Fund
21.00%
Investment Advisor
13.69%
Research Firm
3.11%
Sovereign Wealth Fund
1.80%
Private Equity
0.82%
Pension Fund
0.79%
Bank and Trust
0.60%
Individual Investor
0.21%
기타
32.16%
기관 주식 보유
마지막 업데이트: Sun, Apr 5
마지막 업데이트: Sun, Apr 5
보고 기간
기관 수
보유 주식
비율
변동
2026Q1
1452
147.12M
77.07%
-48.70M
2025Q4
1286
180.92M
105.49%
--
2025Q3
1352
180.95M
106.13%
-112.86K
2025Q2
1416
180.92M
107.16%
-6.42M
2025Q1
1400
186.11M
105.23%
-12.34M
2024Q4
1391
186.68M
107.44%
-1.15M
2024Q3
1351
188.95M
104.99%
+4.63M
2024Q2
1335
183.23M
95.81%
+15.73M
2024Q1
1330
166.64M
95.05%
-5.91M
2023Q4
1339
163.38M
96.52%
-2.83M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
HBK Investments, L.P.
7.65M
4.01%
+7.65M
--
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
7.28M
3.81%
+121.88K
+1.70%
Dec 31, 2025
Pentwater Capital Management LP
7.25M
3.8%
+7.25M
--
Dec 31, 2025
BlackRock Financial Management, Inc.
5.00M
2.62%
+3.56M
+247.46%
Dec 31, 2025
State Street Investment Management (US)
4.18M
2.19%
-1.01M
-19.48%
Dec 31, 2025
Balyasny Asset Management LP
4.09M
2.14%
+3.24M
+382.56%
Dec 31, 2025
Millennium Management LLC
3.44M
1.8%
+1.22M
+55.20%
Dec 31, 2025
Norges Bank Investment Management (NBIM)
3.43M
1.8%
+2.52M
+276.89%
Dec 31, 2025
Geode Capital Management, L.L.C.
3.33M
1.75%
+19.75K
+0.60%
Dec 31, 2025
MFS Investment Management
2.72M
1.42%
-1.10M
-28.83%
Dec 31, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
First Trust Nasdaq Lux Digi Health Solutions ETF
4.48%
Invesco Biotechnology & Genome ETF
3.72%
First Trust NYSE Arca Biotechnology Index Fund
3.72%
Alger Mid Cap 40 ETF
3.61%
Clough Select Equity ETF
3.13%
Clough Hedged Equity ETF
2.78%
iShares Health Innovation Active ETF
2.72%
State Street SPDR S&P Biotech ETF
2.32%
First Trust Indxx Medical Devices ETF
2.22%
ROBO Global Healthcare Technology & Innovation ETF
2.03%
더 보기
First Trust Nasdaq Lux Digi Health Solutions ETF
비율4.48%
Invesco Biotechnology & Genome ETF
비율3.72%
First Trust NYSE Arca Biotechnology Index Fund
비율3.72%
Alger Mid Cap 40 ETF
비율3.61%
Clough Select Equity ETF
비율3.13%
Clough Hedged Equity ETF
비율2.78%
iShares Health Innovation Active ETF
비율2.72%
State Street SPDR S&P Biotech ETF
비율2.32%
First Trust Indxx Medical Devices ETF
비율2.22%
ROBO Global Healthcare Technology & Innovation ETF
비율2.03%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
